BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38446203)

  • 1. Factors related to central nervous system involvement of primary vitreoretinal lymphoma.
    Kim JY; Kim JJ; Kim RY; Kim M; Park YG; Park YH
    Graefes Arch Clin Exp Ophthalmol; 2024 Mar; ():. PubMed ID: 38446203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Porcu P; Martinez NL; Glass J; Mashayekhi A; Shields CL
    Asia Pac J Ophthalmol (Phila); 2020; 9(2):110-116. PubMed ID: 31923035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018.
    Castellino A; Pulido JS; Johnston PB; Ristow KM; Nora Bennani N; Inwards DJ; Macon WR; Micallef INM; King RL; Salomao DR; Witzig TE; Habermann TM; Nowakowski GS
    Am J Hematol; 2019 Mar; 94(3):291-298. PubMed ID: 30516868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center.
    Dalvin LA; Lim LS; Ancona-Lezama D; Mazloumi M; Chang M; Mashayekhi A; Shields CL
    Ophthalmol Retina; 2019 Nov; 3(11):998-1005. PubMed ID: 31358444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Features and Treatment Outcomes of Vitreoretinal Lymphoma according to Its Association with CNS Lymphoma.
    Cho BJ; Kim DY; Park UC; Lee JY; Yoon YH; Yu HG
    Ocul Immunol Inflamm; 2018; 26(3):365-371. PubMed ID: 29394118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between vitreoretinal lymphoma and the site of lymphoma development in the central nervous system.
    Maruyama K; Iwahashi C; Hashida N; Ohguro N; Nishida K
    Jpn J Ophthalmol; 2022 Mar; 66(2):142-150. PubMed ID: 34860298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy.
    Gozzi F; Aldigeri R; Mastrofilippo V; De Simone L; Bolletta E; Marzano J; Iannetta D; Coassin M; Ilariucci F; Ferrari A; Luminari S; Merli F; Croci S; Zerbini A; Farnetti E; Nicoli D; Valli R; Tamagnini I; Cavazza A; Salvarani C; Fontana L; Cimino L
    Ocul Immunol Inflamm; 2022; 30(7-8):1833-1841. PubMed ID: 34379571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectral-domain optical coherence tomography biomarkers in vitreoretinal lymphoma.
    Guan W; Xiao Y; Zhao H; Hu F; Chen C; Peng X
    Clin Exp Ophthalmol; 2023 Mar; 51(2):144-153. PubMed ID: 36567492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
    Kaburaki T; Taoka K
    Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration.
    Dalvin LA; Pulido JS; Shields CL; Marchese A; Miserocchi E; Frenkel S; Pe'er J
    Eye (Lond); 2023 Jan; 37(1):54-61. PubMed ID: 34999721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive overview of diagnosis, imaging and treatment of vitreoretinal lymphoma.
    Menean M; Giuffrè C; Cicinelli MV; Marchese A; Modorati G; Bandello F; Miserocchi E
    Eur J Ophthalmol; 2023 Nov; ():11206721231211931. PubMed ID: 37956540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
    Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
    Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of cytokine analysis in the diagnosis and efficacy monitoring of vitreoretinal lymphoma.
    Kang H; Tao Y
    Int J Ophthalmol; 2022; 15(12):1893-1902. PubMed ID: 36536977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of combined intravitreal methotrexate and systemic high-dose methotrexate therapy in vitreoretinal lymphoma.
    Cheng CL; Yeh PT; Fang WQ; Ma WL; Hou HA; Tsai CH; Lin CP; Tien HF
    Cancer Med; 2023 Apr; 12(7):8102-8111. PubMed ID: 36602288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-scan ultrasound and cytology of the vitreous in primary central nervous system lymphoma with vitreoretinal involvement.
    Lai J; Chen K; Shi HM; Zhuang L; Zhou X; Xiao JJ; Li Y; Chen BB; Wang QP
    Int J Ophthalmol; 2019; 12(6):1001-1007. PubMed ID: 31236360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
    Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
    Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
    Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
    Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APRIL and BAFF play a key role in differentiating vitreoretinal lymphoma from uveitis.
    Tian S; Chen K; Xiao J; Wang D; Zhou X; Li X; Shi H; Li Y; Cao X; Guan M; Chen B; Wang Q
    Clin Chim Acta; 2022 Oct; 535():1-6. PubMed ID: 35820532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma.
    Chen K; Li X; Wang D; Ma Y; Chen B; Wang Q; Ma J; Guan M
    Clin Chim Acta; 2021 Apr; 515():21-26. PubMed ID: 33387464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.
    Motomura Y; Yoshifuji K; Tachibana T; Takase H; Arai A; Tanaka K; Okada K; Nogami A; Umezawa Y; Sakashita C; Yamamoto M; Mori T; Nagao T
    Br J Haematol; 2024 Apr; 204(4):1279-1287. PubMed ID: 38131400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.